CD8A and neoplasm: Mutations in both RAS and BRAF perpetuates kinase activation, leading not only to cell growth, invasion, and metastases, but also to tumor microenvironment differentiation, and have been shown to reduce T cell CD8+ infiltration and diminish neoantigen presentation by impairing the interferon pathway.